Fatal breast cancer risk in relation to use of unopposed estrogen and combined hormone therapy

Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in the Women’s Health Initiative Observational Study

(2013) Rowan T. Chlebowski et al.   JNCI-Journal of the National Cancer Institute

Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial

(2012) Garnet L Anderson et al.   LANCET ONCOLOGY

Bilateral Oophorectomy in Relation to Risk of Postmenopausal Breast Cancer: Confounding by Nonmalignant Indications for Surgery?

(2011) H. B. Nichols et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Breast Cancer Risk and Ovariectomy, Hysterectomy, and Tubal Sterilization in the Women's Contraceptive and Reproductive Experiences Study

(2010) D. J. Press et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Age-related variation in the relationship between menopausal hormone therapy and the risk of dying from breast cancer

(2010) Kerryn W. Reding et al.   BREAST CANCER RESEARCH AND TREATMENT

Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal Women

(2010) Rowan T. Chlebowski et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Benefits and Risks of Postmenopausal Hormone Therapy When It Is Initiated Soon After Menopause

(2009) Ross L. Prentice et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Estrogen Plus Progestin and Breast Cancer Detection by Means of Mammography and Breast Biopsy

(2008) Rowan T. Chlebowski   ARCHIVES OF INTERNAL MEDICINE

Prediagnostic Use of Hormone Therapy and Mortality After Breast Cancer

(2008) P. A. Newcomb et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION